Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News CVRx Inc CVRX

Healthcare Medical Devices
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It... see more

Current News (NDAQ:CVRX)

CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

GlobeNewswire 1 day ago

Wolf Popper LLP Announces Investigation on Behalf of CVRx, Inc. Investors

GlobeNewswire 10 days ago

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance

GlobeNewswire 11 days ago

CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

GlobeNewswire January 6, 2026

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 22, 2025

CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire November 19, 2025

CVRx Reports Third Quarter 2025 Financial and Operating Results

GlobeNewswire November 5, 2025

CVRx to Present at the Jefferies Global Healthcare Conference in London

GlobeNewswire November 4, 2025

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

GlobeNewswire October 22, 2025
View More News ››

Opinion & Analysis (NDAQ:CVRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CVRX)

Be the first to post on this bullboard.

Electrum Discovery Corp.

Electrum Discovery Corp.

Electrum Discovery Corp. engages in the acquisition and exploration of mineral properties in the natural resource sector in ...
View More »

Podcasts